专家介绍
刘相燕
社会兼职
中国抗癌协会肿瘤微创治疗专业委员会肺癌微创治疗分会委员（国家级），山东省医学会胸外科分会委员，山东省医学会食管外科专业组副组长，山东省抗癌协会胸部肿瘤专业委员会委员等。
优势擅长
更多发表论文
1. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. J Exp Clin Cancer Res. 2015 Dec 15; 34. 通讯作者
2. The upregulation of miRNA-146a inhibited biological behaviors of ESCC through inhibition of IRS2. Tumour Biol. 2016 Apr;37(4).通讯作者
3. PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma. Tumour Biol. 2015 Aug;36(8).通讯作者
4. Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies. Cancer Chemother Pharmacol. 2015 May;75(5).通讯作者
5. Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy. Med Oncol. 2015 Feb;32(2).通讯作者
6. Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. Med Oncol. 2014 Dec;31(12).通讯作者
7. The relationship between activated K-ras and HLA class I antigen downregulation in metastasis of non-small cell lung cancer. J Int Med Res. 2013;41(5). 通讯作者
8. CCR7: A Metastasis and Prognosis Indicator of Postoperative Patients with Esophageal Carcinoma. Hepatogastroenterology. 2013 ;60(124).第一作者
详细>>
